SlideShare a Scribd company logo
1 of 23
Primary Human Cell Systems Analysis of Drug Mechanisms Ellen L. Berg, PhD BioSeek, Inc. SBS 15th Annual Conference Lille, France 28 April 2009 Bio Seek
Presentation Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Goals for Human Cell Systems Biology Platform
BioMAP ®   Technology Platform Complementary to biochemical target and phenotypic screening  Assays Human primary cells  Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
[object Object],[object Object],[object Object],[object Object],[object Object],BioMAP ®   Technology Platform Assays Human primary cells  Disease-like culture conditions >25 BioMAP Systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LPS BF4T SM3C
Assays Human primary cells  Disease-like culture conditions Profile Database Biological responses to drugs and stored in the database BioMAP ®   Technology Platform ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LPS BF4T SM3C
Assays are Robust and Highly Reproducible  High Correlation of Experimental Replicates 5   M dose Pearson Correlation Coefficient Consistent data experiment-to-experiment  Pearson correlation >0.8 (perfect match = 1)
Microtubule Stabilizers Mitochondrial  ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism  Pairwise Correlation of BioMAP Reveals Functional Similarities  mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription
BioMAP Systems are Validated   Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance  envelope Dose Response
E-selectin TNF-  IL-8 BioMAP Systems are Validated  Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy  Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2  decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
Project Goal ,[object Object],[object Object],[object Object],[object Object],PPAR  PPAR  Rosiglitazone (Avandia) Troglitazone (Resulin) Pioglitazone (Actos) Fenofibrate (Tricor)
BioMAP Profile of Rosiglitazone Eot3 IP-10 I-TAC VCAM E-sel Monocyte activation Macrophage activation T cell  activation MCP-1 TNF  MCSF CD40 IL-8 IP-10 I-TAC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BioMAP Systems
BioMAP Profile of Rosiglitazone Eot3 IP-10 I-TAC MMP9 VCAM E-sel Monocyte activation Macrophage activation T cell  activation MCP-1 TNF  MCSF CD40 IL-8 uPAR Col III Col IV PAI-1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Col III BioMAP Systems
BioMAP Profile of Rosiglitazone ,[object Object],[object Object],[object Object],PGJ2 PGF1a PGD2 PGF2a PGD2 PGF2a PGJ2 PGF1a PGJ2 PG1a PGE2 PGD2 PGF2a PGF2a Leukocyte-containing systems Bronchial epithelial cell-containing systems BioMAP Systems
Upregulation of Prostaglandins by Rosiglitazone ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rosiglitazone Upregulation of PGE2 is not a Class Effect Search of BioMAP Database for Compounds that Increase PGE2 Retinoids Microtubule Destabilizers TXA2 inhibitor PPAR  PPAR  RNA Synthesis Inhibitor mTOR Inhibitor AMPK activator JNK Inhibitor CYP450 Inhibitor Compound Specific Effect Mechanism Class Effect
BioMAP Profile of Pioglitazone MMP9 IL-8 Monocyte activation MCSF CD40 ITAC MCP-1 CD38 T cell  activation PGJ2 PGD2 PGF2a PGJ2 PGD2 PGE2 PGF2a PGJ2 PGD2 PGF2a PGF1a PGJ2 PGD2 PGF2a PGF1a VCAM CD40 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BioMAP Profile of Troglitazone Eot3 IP-10 I-TAC MMP9 E-sel Monocyte activation Macrophage activation T cell  activation TNF  uPAR MCP-1 TF Col III Col IV MMP1 TM MCP-1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],PGF1a PGD2 PGF2a PGF1a PGD2 PGF2a
BioMAP Profile of Fenofibrate - PPAR  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Eot3 IL-8 MMP9 Monocyte activation T cell  activation MCSF CD69 uPAR HLA-DR TM Col III MMP1 IL-8 MCP-1 PGJ2 PGD2 PGF2a PGJ2 PGD2 PGF2a PGD2 PGE2 PGF2a PGF1a PGJ2 PGD2 PGF2a PGF1a Mig VCAM ITAC VCAM IL1  IL-8 TM
Summary of PPAR Agonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 

More Related Content

What's hot

Tyrosinekinase inhibitors rahul
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahulRahul Sankar
 
Important inhibitors of protein synthesis
Important inhibitors of protein synthesisImportant inhibitors of protein synthesis
Important inhibitors of protein synthesisEmaSushan
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinasesfondas vakalis
 
Tyrosine kinase report
Tyrosine kinase reportTyrosine kinase report
Tyrosine kinase reportjinx11
 
Cancer signal-transduction
Cancer signal-transductionCancer signal-transduction
Cancer signal-transductionDeepika Tripathi
 
Regulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOReadvisor
 
Proteomics of Hormone Fragments 111112
Proteomics of Hormone Fragments 111112Proteomics of Hormone Fragments 111112
Proteomics of Hormone Fragments 111112Roshan Kumar
 
Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms finalmosaiques
 
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...Bholakant raut
 
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerNovel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerZuleika86
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseGedion Yilma
 
gonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's diseasegonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's diseaseSurbhiPanwar5
 
Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .heenakazi4
 
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...bioejjournal
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...bioejjournal
 
Ardi - Tsri 2008
Ardi - Tsri 2008Ardi - Tsri 2008
Ardi - Tsri 2008vcardi
 

What's hot (20)

Tyrosinekinase inhibitors rahul
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahul
 
Important inhibitors of protein synthesis
Important inhibitors of protein synthesisImportant inhibitors of protein synthesis
Important inhibitors of protein synthesis
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinases
 
Tyrosine kinase report
Tyrosine kinase reportTyrosine kinase report
Tyrosine kinase report
 
Cancer signal-transduction
Cancer signal-transductionCancer signal-transduction
Cancer signal-transduction
 
Regulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOR
 
Proteomics of Hormone Fragments 111112
Proteomics of Hormone Fragments 111112Proteomics of Hormone Fragments 111112
Proteomics of Hormone Fragments 111112
 
Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms final
 
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
 
Immunosupressants
Immunosupressants Immunosupressants
Immunosupressants
 
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerNovel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
 
Tyrosine kinase ppt
Tyrosine kinase pptTyrosine kinase ppt
Tyrosine kinase ppt
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinase
 
Presentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolismPresentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolism
 
srep43028
srep43028srep43028
srep43028
 
gonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's diseasegonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's disease
 
Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .
 
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...
 
Ardi - Tsri 2008
Ardi - Tsri 2008Ardi - Tsri 2008
Ardi - Tsri 2008
 

Similar to Primary Human Cell Systems Analysis of Drug Mechanisms

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP® Systems
 
Panitumumab (vectibix)
Panitumumab (vectibix)Panitumumab (vectibix)
Panitumumab (vectibix)Vibhay Pareek
 
P glycoprotein
P glycoprotein P glycoprotein
P glycoprotein khaterehz
 
Insulin resistance 2013
Insulin resistance 2013Insulin resistance 2013
Insulin resistance 2013Elsa von Licy
 
The PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer pptThe PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer pptBernard Bahaah
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyinemet
 
Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsDiscoverX Corporation
 
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...BioMAP® Systems
 
From Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensingFrom Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensingNorwich Research Park
 
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...KayvonneFerguson
 
Cd117 Dako Research Paper
Cd117 Dako Research PaperCd117 Dako Research Paper
Cd117 Dako Research PaperAngela Williams
 
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Ellen Berg
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...BioMAP® Systems
 
Stat3 &other target proteins in psoriasis by yousry a mawla
Stat3 &other target  proteins    in  psoriasis by yousry a mawlaStat3 &other target  proteins    in  psoriasis by yousry a mawla
Stat3 &other target proteins in psoriasis by yousry a mawlaM.YOUSRY Abdel-Mawla
 
Postranslational Modification
Postranslational ModificationPostranslational Modification
Postranslational ModificationBahaddin Ahmad
 

Similar to Primary Human Cell Systems Analysis of Drug Mechanisms (20)

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
 
Biochemistry of hormones
Biochemistry of hormonesBiochemistry of hormones
Biochemistry of hormones
 
Panitumumab (vectibix)
Panitumumab (vectibix)Panitumumab (vectibix)
Panitumumab (vectibix)
 
P glycoprotein
P glycoprotein P glycoprotein
P glycoprotein
 
Insulin resistance 2013
Insulin resistance 2013Insulin resistance 2013
Insulin resistance 2013
 
The PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer pptThe PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer ppt
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
 
Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to Combinations
 
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
 
From Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensingFrom Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensing
 
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
 
Tocolytic (Fartoks)
Tocolytic (Fartoks)Tocolytic (Fartoks)
Tocolytic (Fartoks)
 
Nc3R\'s Meeting
Nc3R\'s MeetingNc3R\'s Meeting
Nc3R\'s Meeting
 
Cd117 Dako Research Paper
Cd117 Dako Research PaperCd117 Dako Research Paper
Cd117 Dako Research Paper
 
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
 
Host modulation
Host modulationHost modulation
Host modulation
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Stat3 &other target proteins in psoriasis by yousry a mawla
Stat3 &other target  proteins    in  psoriasis by yousry a mawlaStat3 &other target  proteins    in  psoriasis by yousry a mawla
Stat3 &other target proteins in psoriasis by yousry a mawla
 
Postranslational Modification
Postranslational ModificationPostranslational Modification
Postranslational Modification
 

More from BioMAP® Systems

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioMAP® Systems
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...BioMAP® Systems
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
 
BioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioMAP® Systems
 
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsBioMAP® Systems
 
Introduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsBioMAP® Systems
 
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...BioMAP® Systems
 

More from BioMAP® Systems (7)

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
 
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
 
Primary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug Mechanisms
 
BioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioSeek EPA ToxCast Program
BioSeek EPA ToxCast Program
 
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
 
Introduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> Systems
 
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
 

Primary Human Cell Systems Analysis of Drug Mechanisms

  • 1. Primary Human Cell Systems Analysis of Drug Mechanisms Ellen L. Berg, PhD BioSeek, Inc. SBS 15th Annual Conference Lille, France 28 April 2009 Bio Seek
  • 2.
  • 3.
  • 4. BioMAP ® Technology Platform Complementary to biochemical target and phenotypic screening Assays Human primary cells Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
  • 5.
  • 6.
  • 7. Assays are Robust and Highly Reproducible High Correlation of Experimental Replicates 5  M dose Pearson Correlation Coefficient Consistent data experiment-to-experiment Pearson correlation >0.8 (perfect match = 1)
  • 8. Microtubule Stabilizers Mitochondrial ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism Pairwise Correlation of BioMAP Reveals Functional Similarities mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription
  • 9. BioMAP Systems are Validated Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance envelope Dose Response
  • 10. E-selectin TNF-  IL-8 BioMAP Systems are Validated Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2 decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Rosiglitazone Upregulation of PGE2 is not a Class Effect Search of BioMAP Database for Compounds that Increase PGE2 Retinoids Microtubule Destabilizers TXA2 inhibitor PPAR  PPAR  RNA Synthesis Inhibitor mTOR Inhibitor AMPK activator JNK Inhibitor CYP450 Inhibitor Compound Specific Effect Mechanism Class Effect
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.  

Editor's Notes

  1. 2 1
  2. BioMAP systems are complex primary human cell based disease models that can be used directly for phenotypic screening. The most attractive feature of this platform, however, is it’s ability of the platform to provide target and pathway mechanisms of action. This enables reverse pharmacology of bioactive agents and drugs as well as in depth characterization of leads for identifying on versus off-target biology, which in turn impact safety and also clinical indication selection.